▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

McCormick & Co. Q3 21 Earnings Conference Call At 8:00 AM ET

By RTTNews Staff Writer ✉ | Published: 9/30/2021 6:00 AM ET

McCormick & Co. (MKC) will host a conference call at 8:00 AM ET on September 30, 2021, to discuss Q3 21 earnings results.

To access the live webcast, log on to http://ir.mccormick.com

For a replay call, dial 877-660-6853 (US) or 201-612-7415 (International) with conference ID number 13722560.

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In February 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech Stocks Facing FDA Decision In December 2022

Biotech Stocks Facing FDA Decision In December 2022

Latest Updates on COVID-19

Covid-19 Remains An International Emergency: WHO

U.S. Covid Metrics Signal Ease In Pandemic

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

US Covid Deaths Rise By 78% In 2 Weeks

78% Increase In US Covid Deaths In A Fortnight

Read More

COVID-19: Drugs in Development

RELATED NEWS

McCormick & Co. Q4 22 Earnings Conference Call At 8:00 AM ET

McCormick Guides FY23 Adj. EPS Below Estimates - Update

McCormick & Co. Q4 Profit Decreases, misses estimates

Follow RTT

Editor's Pick
Most Read
Most Emailed

Exxon Mobil Q4 Results Top Estimates

Daiso Recalls Matsunaga Mini Shiruko Sand Biscuits

Court Rejects J&J Bankruptcy Petition To End Talc Cancer Lawsuits

Frozen, Fully Cooked Jambalaya And Gumbo Products Recalled

GE HealthCare Q4 Profit Declines

Toyota Is World's Top-selling Automaker Again

Rao's Slow Simmered Soup, Chicken & Gnocchi Recalled

Daniele Intl Recalls Ready-to-Eat Sausage Products

Chevron Q4 Profit Up 25%, But Misses Estimates

ZLINE Expands Recall Of Gas Ranges

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

Drizzilicious Mini Rice Cake Bites, Popcorn Recalled

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

Biotech Stocks Facing FDA Decision In February 2023

Syros Gets Fast Track Designation In U.S. For Tamibarotene For Myelodysplastic Syndrome Treatment

Sartorius Stedim Biotech FY22 Profit Rises, Orders Down; Sees Growth In FY23; Raises FY25 Sales View

Evotec Partners With Janssen Biotech To Develop Immune-based Cancer Therapies

Resmed Inc Q2 Profit Increases, beats estimates

Sartorius FY22 Prelim Earnings, Revenue Rise

Merck's KEYTRUDA Gets FDA Approval To Treat Stage IB, II, IIIA Non-small Cell Lung Cancer Patients

Regeneron Pharma: CHMP Adopts Positive Opinion For Dupixent

Eisai : EMA Accepts MAA For Lecanemab As Treatment For Early Alzheimer's Disease

Ipsen: CHMP Recommends Not To Grant Marketing Authorization For Palovarotene As Treatment For FOP

Lucid Group Opens First Retail Studio And Service Centre In Quebec

Sanmina Corporation Q1 Profit Increases, beats estimates

Telia Co. Slips To Hefty Loss In Q4, Net Sales Rise; Cuts Dividend

Goodyear Tire & Rubber Announces Cost Savings Actions; Q4 Results Fell Short Of Its Expectations

Pitney-Bowes Q4 Profit Increases, but misses estimates

Dole To Sell Fresh Vegetables Division To Fresh Express For $293 Mln Cash

American Airlines Group Q4 Profit Tops Estimates; Achieves Record Revenue

OSI Systems Q2 Profit Down, But Above Estimates - Update

Superdry Posts Wider Adj. Pretax Loss In H1, Revenue Up 3.6%; Revises Outlook

Volvo Group Q4 Adj. Operating Profit Rises; Adj. Net Sales Up 17%

Alexandria Real Estate Equities, Inc. Bottom Line Declines In Q4, misses estimates

KLA Corporation Q2 Profit Increases, beats estimates

GE HealthCare Gains On Improved Revenues